A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
Clinical trial NCT01896531 · COMPLETED
Trial details
- NCT number
- NCT01896531
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-14
- Primary completion
- 2015-06-03
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.